Virology News and Research

Latest Virology News and Research

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

According to a recent announcement made by Public Health England, there is a global shortage of vaccines used against hepatitis B infection. This announcement is followed up by a “prioritisation guidance” which means that persons who are at greatest risk of getting hepatitis B are to be vaccinated on priority if they have not received the vaccine before.

7 Aug 2017

Congress revamps housing program to benefit areas where HIV is spreading

In a bipartisan push, Congress has restructured a federal program that provides housing assistance for people living with HIV to funnel more money into areas struggling to control the outbreak.

7 Aug 2017

Accidental discovery opens up new way to find unknown viruses

A chance discovery has opened up a new method of finding unknown viruses. In research published in the journal Virus Evolution, scientists from Oxford University's Department of Zoology have revealed that Next-Generation Sequencing and its associated online DNA databases could be used in the field of viral discovery.

4 Aug 2017

Prior flavivirus disease does not worsen Zika infection in rhesus macaques

Rhesus macaques previously infected with dengue or yellow fever viruses appear to be neither more nor less susceptible to severe infection with Zika virus, according to new research published in PLOS Pathogens.

4 Aug 2017

Mouse model developed to allow study of Zika virus transmission

Scientists at the National Institutes of Health have developed a mouse model to study the sexual and fetal transmission of Zika virus. This will enable studies to further understanding of how the Zika virus spreads, thereby allowing treatments to be developed.

4 Aug 2017

Georgia State receives high research funding to set record for sixth consecutive year

Georgia State University received $147 million in research funding in fiscal year 2017, setting a record for the sixth consecutive year.

4 Aug 2017

New study shows how gut microbes can prevent severe flu infections in mice

Microbes that live in the gut don't just digest food. They also have far-reaching effects on the immune system.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Tiny molecule in the immune system could help develop cure for common cold

A tiny molecule found in the immune systems of humans and animals could be used to develop a cure for the common cold, new research suggests.

3 Aug 2017

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Representatives from the London Assembly and local authorities in the Capital are set to meet with third sector and public health representatives in a roundtable meeting hosted by biopharmaceutical company, AbbVie, on World Hepatitis Day.

3 Aug 2017

Ebola virus RNA can persist in semen of survivors two years after infection, researchers say

Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found.

2 Aug 2017

UM SOM researchers to study adaptive immune responses of infants with HIV exposure in utero

The University of Maryland School of Medicine's Institute for Global Health and the Institute of Human Virology have been awarded a $2 million five-year grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the impact exposure to HIV has on the immune systems of infants in utero and how those changes impact the ability of infants to fight off infections after birth.

2 Aug 2017

Sexual transmission of Zika virus reported in Florida

Yesterday, Florida Department of Health reported the first case of sexually transmitted Zika virus this year.

2 Aug 2017

Study shows how climate change affects Europe's most dangerous pathogens

The impact of climate change on the emergence and spread of infectious diseases could be greater than previously thought, according to new research by the University of Liverpool.

2 Aug 2017

TUM scientists provide new insights into development of T cells

When T cells encounter an antigen, they proliferate and produce various types of daughter cells. A team at the Technical University of Munich has now refuted the prevailing hypothesis that this immune response is largely predetermined by the individual structure of the T cell receptor.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

Researchers identify new methods that could improve treatment for infectious diseases

Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

2 Aug 2017

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.

1 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

Virology News and Research

Latest Virology News and Research

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

Congress revamps housing program to benefit areas where HIV is spreading

Accidental discovery opens up new way to find unknown viruses

Prior flavivirus disease does not worsen Zika infection in rhesus macaques

Mouse model developed to allow study of Zika virus transmission

Georgia State receives high research funding to set record for sixth consecutive year

New study shows how gut microbes can prevent severe flu infections in mice

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Tiny molecule in the immune system could help develop cure for common cold

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Ebola virus RNA can persist in semen of survivors two years after infection, researchers say

UM SOM researchers to study adaptive immune responses of infants with HIV exposure in utero

Sexual transmission of Zika virus reported in Florida

Study shows how climate change affects Europe's most dangerous pathogens

TUM scientists provide new insights into development of T cells

Shaping the future of oncology treatment

Researchers identify new methods that could improve treatment for infectious diseases

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production